Tirofiban and eptifibatide, but not abciximab, induce leukocyte-platelet aggregation

被引：0
|
作者：
Furman, MI
Krueger, LA
Frelinger , AL
Barnard, MR
Mascelli, MA
Nakada, MT
Michelson, AD
机构：
[1] Univ Massachusetts, Sch Med, Worcester, MA USA
[2] Centocor Inc, Malvern, PA USA
来源：
CIRCULATION | 1999年 / 100卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3591
引用
收藏
页码：681 / 681
页数：1
相关论文
共 50 条
  • [31] Abacavir induces platelet activation and increases leukocyte-platelet interactions
    Rios-Navarro, C.
    Collado-Diaz, V.
    Roupain, N.
    Orden, S.
    de Pablo, C.
    Martnez-Cuesta, M. A.
    Esplugues, J. V.
    Alvarez, A.
    ANTIVIRAL THERAPY, 2014, 19 : A37 - A38
  • [32] CARDIOPULMONARY BYPASS INDUCES LEUKOCYTE-PLATELET ADHESION
    RINDER, CS
    BONAN, JL
    RINDER, HM
    MATHEW, J
    HINES, R
    SMITH, BR
    BLOOD, 1992, 79 (05) : 1201 - 1205
  • [33] Effects of physiologic agonists on canine whole blood flow cytometry assays of leukocyte-platelet aggregation and platelet activation
    Tarnow, Inge
    Kristensen, Annemarie T.
    Krogh, Anne K. R.
    Frelinger, Andrew L., III
    Barnard, Marc R.
    Michelson, Alan D.
    VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY, 2008, 123 (3-4) : 345 - 352
  • [34] Leukocyte-platelet interaction in pregnancies complicated with preeclampsia
    Holthe, MR
    Lyberg, T
    Staff, AC
    Berge, LN
    PLATELETS, 2005, 16 (02) : 91 - 97
  • [35] Time course, magnitude, and consistency of platelet inhibition by abciximab, tirofiban, or eptifibatide in patients with unstable angina pectoris undergoing percutaneous coronary intervention
    Kereiakes, DJ
    Broderick, TM
    Roth, EM
    Whang, D
    Shimshak, T
    Runyon, JP
    Hattemer, C
    Schneider, J
    Lacock, P
    Mueller, M
    Abbottsmith, CW
    AMERICAN JOURNAL OF CARDIOLOGY, 1999, 84 (04) : 391 - 395
  • [36] Leukocyte-platelet interaction in pregnancy complicated with preeclampsia
    Holthe, MR
    Staff, AC
    Berge, LN
    Lyberg, T
    PLACENTA, 2004, 25 (8-9) : A45 - A45
  • [37] Randomized comparison of dalteparin vs. unfractionated heparin in combination with abciximab during percutaneous coronary intervention: Effects on leukocyte-platelet aggregation, platelet activation and GP IIb/IIIa receptor expression
    Kereiakes, DJ
    Michelson, AD
    Krueger, LA
    Mueller, MN
    Broderick, TM
    Schneider, JF
    Howard, W
    Fox, M
    Barnard, M
    Furman, MI
    CIRCULATION, 2001, 104 (17) : 38 - 38
  • [38] Comparison of the number of patients needed to treat with abciximab, eptifibatide and tirofiban to prevent death or myocardial infarction
    Wilson, MG
    Jamal, HH
    Wischet, W
    Reid, P
    EUROPEAN HEART JOURNAL, 2000, 21 : 650 - 650
  • [39] Meta-analysis of effectiveness and safety of abciximab versus eptifibatide or tirofiban in percutaneous coronary intervention
    Brown, DL
    Fann, CSJ
    Chang, CJ
    AMERICAN JOURNAL OF CARDIOLOGY, 2001, 87 (05) : 537 - 541
  • [40] Randomized comparison of dalteparin versus unfractionated heparin in combination with abciximab during percutaneous coronary intervention: Effects on leukocyte-platelet aggregation, platelet activation, and glycoprotein IIb/IIIa receptor expression.
    Kereiakes, D
    Michelson, A
    Krueger, L
    Mueller, M
    Broderick, T
    Schneider, J
    Howard, W
    Fox, M
    Barnard, M
    Furman, M
    AMERICAN JOURNAL OF CARDIOLOGY, 2001, 88 (5A) : 97G - 97G
12345